Infliximab in hidradenitis suppurativa: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Infliximab in hidradenitis suppurativa: A systematic review and meta‐analysis

Published:2022-07-18 Issue:9 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Shih Terri¹,Lee Katrina²,Grogan Tristan³,De Devea R.⁴,Shi Vivian Y.⁵^ORCID,Hsiao Jennifer L.⁶^ORCID

Affiliation:

1. David Geffen School of Medicine University of California Los Angeles Los Angeles California USA

2. Department of Dermatology University of California Los Angeles Los Angeles California USA

3. Department of Medicine Statistics Core, David Geffen School of Medicine University of California Los Angeles California USA

4. Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo New York USA

5. Department of Dermatology University of Arkansas for Medical Sciences Little Rock Arkansas USA

6. Department of Dermatology University of Southern California Los Angeles California USA

Funder

National Center for Advancing Translational Sciences

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15691

Reference32 articles.

1. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

2. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

3. WellsG SheaB O'ConnellD et al.The Newcastle–Ottawa scale (NOS) for assessing the quality of non‐randomized studies in meta‐analysis.2000. Accessed September 30 2021.http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

4. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa

5. High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report of successful treatment of follicular occlusion triad with adalimumab and research progress on biologic therapy for follicular occlusion triad;Journal of Dermatological Treatment;2024-09-09

2. Infliximab inhibits TNF-α-dependent activation of the NLRP3/IL-1β pathway in acne inversa;Heliyon;2024-06

3. S2k‐Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa – Kurzfassung;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-06

4. Efectividad y seguridad de los fármacos biológicos y las moléculas pequeñas en la hidradenitis supurativa: experiencia en un centro terciario y propuesta de un algoritmo terapéutico;Piel;2024-06

5. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-05-21